Molecule Details
InChIKeyRUOKEQAAGRXIBM-GFCCVEGCSA-N
Compound NameRasagiline
Canonical SMILESC#CCN[C@@H]1CCc2ccccc21
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)4
Pfam Stratification Cross-Family
Avg pChEMBL7.54
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB01367
Drug NameRasagiline
CAS Number136236-51-6
Groups approved investigational
ATC Codes N04BD02
DescriptionRasagiline is an irreversible inhibitor of monoamine oxidase and is used as a monotherapy in early Parkinson's disease or as an adjunct therapy in more advanced cases.

Categories: Agents that produce hypertension Agents that reduce seizure threshold Anti-Parkinson Drugs Antidepressive Agents Central Nervous System Agents Central Nervous System Depressants Compounds used in a research, industrial, or household setting Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 Substrates Dopamine Agents Drugs that are Mainly Renally Excreted Enzyme Inhibitors Hypotensive Agents Indenes Monoamine Oxidase B Inhibitors Monoamine Oxidase Inhibitors Nervous System Neuroprotective Agents Protective Agents Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin Agents Serotonin Modulators
Cross-references: BindingDB: 10989 ChEBI: 63620 CHEMBL887 ChemSpider: 2314553 Drugs Product Database (DPD): 19840 D08469 PDB: RAU PharmGKB: PA164764584 PubChem:3052776 PubChem:46506045 RxCUI: 134748 Therapeutic Targets Database: DAP001107 Wikipedia: Rasagiline ZINC: ZINC000019875504
Target Activities (4)
Target Gene Organism Category Pfam pChEMBL Type Source
P50406 HTR6 Homo sapiens Human PF00001 8.8 Ki ChEMBL;BindingDB
P22303 ACHE Homo sapiens Human PF08674 PF00135 7.7 IC50 ChEMBL;BindingDB
P27338 MAOB Homo sapiens Human PF01593 7.4 IC50 ChEMBL;BindingDB
P21397 MAOA Homo sapiens Human PF01593 6.2 IC50 ChEMBL;BindingDB
DrugBank Target Actions (3)
Target Gene Target Name Action Type
P05177 CYP1A2 Cytochrome P450 1A2 substrate enzymes
P10415 BCL2 Apoptosis regulator Bcl-2 activator targets
P27338 MAOB Amine oxidase [flavin-containing] B inhibitor targets